Actelion Submits New Drug Application for Uptravi in the U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 4:35PM CST
Actelion Ltd. (ALIOF) announced the submission of a new drug application to the FDA for its pulmonary arterial hypertension candidate, Uptravi (selexipag).
ANIP: 55.24 (+1.79), UTHR: 130.22 (+2.40)
Stryker & Osiris Team Up to Market Viable Bone Matrix - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 2:50PM CST
Under the partnership, Stryker Corporation (SYK) will attain exclusive, worldwide rights to Osiris' viable bone matrix under the name BIO4.
ANIP: 55.24 (+1.79), OSIR: 14.87 (+0.13), AFFX: 9.80 (+0.05), SYK: 96.00 (-0.61)
Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 1:30PM CST
During the reported quarter,Myriad Genetics (MYGN) experienced heightened physician demand for the myRisk test.
CYTK: 5.87 (+0.35), MYGN: 36.50 (+0.28), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)
Genomic Health (GHDX) Shines on Prospective Cancer Tests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 4:50PM CST
Genomic Health (GHDX) strongly believes that its Oncotype DX prostate cancer test will strengthen its advanced next generation sequencing (NGS) platform and accelerate the development of future tests.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05), GHDX: 32.44 (+1.32)
Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 12:40PM CST
This latest single-use skin product of Integra (IART) is at present the only pre-meshed bilayer matrix that has been approved by the FDA to treat patients with third-degree burns and the subsequent scar contracture.
BIIB: 340.89 (+5.13), IART: 53.68 (+0.32), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)
Bruker Unveils bioAFM System for High Resolution Imaging - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 1:40PM CST
Bruker's (BRKR) BioScope Resolve provides real-time correlation of atomic force microscopy and optical microscopy data sets
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), BRKR: 19.50 (+0.09), AFFX: 9.80 (+0.05)
Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 5:00PM CST
Alkermes (ALKS) announced the commencement of a phase I extended dosing study on aripiprazole lauroxil for the treatment of schizophrenia.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), AMGN: 160.67 (+3.15), ALKS: 56.16 (+1.02)
Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 4:46PM CST
Acorda (ACOR) has commenced a phase III study on Ampyra for the treatment of post-stroke walking deficits.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), AMGN: 160.67 (+3.15), ACOR: 39.14 (+0.74)
Genomic Health's Breast Cancer Test Yields Positive Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 1:30PM CST
Oncotype DX breast cancer test ??? as Genomic Health's (GHDX) first product ??? has been an important contributor to U.S. invasive breast cancer business revenues since its launch in 2004.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), GHDX: 32.44 (+1.32), AFFX: 9.80 (+0.05)
OvaScience Slumps: OVAS Tanks 12.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 8:06AM CST
OvaScience stock fell over 12% last trading session, reversing its recent trend
BIIB: 340.89 (+5.13), OVAS: 43.73 (+3.22), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)
BioDelivery Sciences (BDSI) in Focus: Stock Tanks 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 8:02AM CST
BioDelivery Sciences has been witnessing a downward trend in its current year loss estimates and its share price has been falling for past few days
BDSI: 12.65 (+0.66), BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)
bluebird bio (BLUE) Crumbles: Stock Falls by 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 7:38AM CST
bluebird bio's shares fell by nearly 6% on the day reversing the uptrend as the stock is now up over 100% since Dec 4.
BLUE: 88.76 (+3.23), BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)
One Stock Chart Trick You Should All Know - Investment Ideas
David Bartosiak - ZACKS - Tue Dec 16, 12:00AM CST
One Stock Chart Trick You Should All Know - Investment Ideas
HSKA: 18.13 (+0.24), ANIP: 55.24 (+1.79), SCMP: 13.75 (+0.44)
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 5:15PM CST
Alexion (ALXN) announced that Soliris has received orphan drug designation in Japan for the treatment of myasthenia gravis.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), ALXN: 181.96 (+3.09), AMGN: 160.67 (+3.15)
Nasdaq makes annual changes to Biotechnology Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:36AM CST
TTPH: 38.86 (+0.53), ZSPH: 43.93 (+1.77), AMRN: 0.99 (unch), OPHT: 44.93 (+1.06), AERI: 29.49 (+1.23), ASPX: 49.93 (-0.10), CNCE: 11.76 (+0.11), ICEL: 5.74 (-0.18), GWPH: 68.08 (+1.82), AUXL: 34.40 (+0.18), RTRX: 12.92 (+0.19), RCPT: 122.05 (+4.05), AAVL: 47.30 (-1.20), AKBA: 11.23 (-0.31), EXPR: 14.96 (+0.32), RARE: 45.17 (-0.56), RLYP: 30.35 (-0.22), PETX: 17.05 (+0.42), ENTA: 49.04 (+0.06), RDUS: 37.17 (+0.11), CARA: 9.78 (+0.02), FLML: 17.01 (-0.98), ALIM: 5.43 (-0.06), ANIP: 55.24 (+1.79), ICPT: 151.49 (+5.85), RVNC: 16.65 (+0.42), POZN: 7.86 (+0.07), FPRX: 26.12 (+0.07), ZFGN: 30.99 (+0.67), CRIS: 1.29 (+0.04), QLTI: 3.72 (+0.08), PCYC: 121.84 (+1.15), PTX: 9.05 (+0.28), CLDN: 18.54 (+0.85), RIGL: 2.22 (+0.02), HPTX: 21.91 (-0.08), AMPH: 11.74 (-0.09), INO: 9.11 (-0.09), VSAR: 22.25 (-0.11), FMI: 23.99 (-0.10), TBPH: 14.84 (+0.20), XLRN: 38.80 (+0.80), MGNX: 33.00 (+0.34), INSM: 15.29 (+0.15), ONTX: 3.82 (+0.06), ALDR: 25.67 (+0.43), SAGE: 38.13 (-0.75), KITE: 51.96 (+0.45), CGEN: 8.58 (-0.17), FOLD: 7.94 (+0.06), KPTI: 37.78 (+1.28)
Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 8:46AM CST
GTX Inc. (GTXI) was a big mover last session, with shares rising roughly 11% on the day.
BIIB: 340.89 (+5.13), GTXI: 0.77 (-0.05), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)
Alder Biopharmaceuticals Slumps: ALDR Falls 5.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 7:55AM CST
Alder Biopharmaceuticals has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for past 24 hours
BIIB: 340.89 (+5.13), ALDR: 25.67 (+0.43), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)
Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 15, 6:10AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 22, 2014.
TTPH: 38.86 (+0.53), ZSPH: 43.93 (+1.77), AMRN: 0.99 (unch), OPHT: 44.93 (+1.06), AERI: 29.49 (+1.23), ASPX: 49.93 (-0.10), CNCE: 11.76 (+0.11), ICEL: 5.74 (-0.18), GWPH: 68.08 (+1.82), AUXL: 34.40 (+0.18), RTRX: 12.92 (+0.19), RCPT: 122.05 (+4.05), AAVL: 47.30 (-1.20), AKBA: 11.23 (-0.31), EXPR: 14.96 (+0.32), RARE: 45.17 (-0.56), ZGNX: 1.20 (+0.04), RLYP: 30.35 (-0.22), PETX: 17.05 (+0.42), ENTA: 49.04 (+0.06), RDUS: 37.17 (+0.11), CARA: 9.78 (+0.02), FLML: 17.01 (-0.98), ALIM: 5.43 (-0.06), ANIP: 55.24 (+1.79), ICPT: 151.49 (+5.85), RVNC: 16.65 (+0.42), POZN: 7.86 (+0.07), NDAQ: 48.74 (-0.40), FPRX: 26.12 (+0.07), CRIS: 1.29 (+0.04), ZFGN: 30.99 (+0.67), QLTI: 3.72 (+0.08), PCYC: 121.84 (+1.15), PTX: 9.05 (+0.28), CLDN: 18.54 (+0.85), RIGL: 2.22 (+0.02), HPTX: 21.91 (-0.08), AMPH: 11.74 (-0.09), INO: 9.11 (-0.09), VSAR: 22.25 (-0.11), FMI: 23.99 (-0.10), TBPH: 14.84 (+0.20), XLRN: 38.80 (+0.80), MGNX: 33.00 (+0.34), INSM: 15.29 (+0.15), ONTX: 3.82 (+0.06), ALDR: 25.67 (+0.43), SAGE: 38.13 (-0.75), KITE: 51.96 (+0.45), CGEN: 8.58 (-0.17), FOLD: 7.94 (+0.06), KPTI: 37.78 (+1.28)
Sangamo Biosciences (SGMO) Jumps: Stock Rises 7.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 8:46AM CST
Sangamo Biosciences (SGMO) was a big mover last session, with shares rising over 7%.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), SGMO: 14.20 (+0.14), AFFX: 9.80 (+0.05)